Medical Providers
A Guide to Substance Abuse Services for Primary Care Clinicians: Treatment Improvement Protocol (TIP) 24
Knowing When To Say When: Transitioning Patients From Opioid Therapy
Minimizing the Misuse of Prescription Opioids in Patients With Chronic Nonmalignant Pain
Introduces health professionals, students, and primary care residents to a standardized approach to the management of patients with chronic nonmalignant pain that integrates techniques for the prevention and detection of misuse of prescription opioids.
The Role of a Prescription Drug Monitoring Program in Reducing Prescription Drug Diversion, Misuse, and Abuse
Provides facts about the benefits of using PDMPs for prescribers, pharmacists, patients, and regulatory and law enforcement agencies.
Effective Treatments for Opioid Addiction
Buprenorphine Treatment for Young Adults
Highlights the findings of the NIDA Clinical Trials Network study that compared longer term versus short-term buprenorphine/naloxone treatment in an outpatient setting. Examines opioid use, treatment with buprenorphine, and further implications for young adults with opioid addiction.
Pharmacologic Guidelines for Treating Individuals With Post-Traumatic Stress Disorder and Co-Occurring Opioid Use Disorders
Offers guidelines for MAT for individuals, particularly veterans, with PTSD and co-occurring OUDs. Covers screening, concomitant treatment, pharmacotherapy, and multiple substances of abuse.
National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use
Provides information on evidence-based treatment of OUD. This guideline is the only document of its kind to include all Food and Drug Administration (FDA)-approved medications in one place.
Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence
Provides guidelines related to opioid dependence that aim to: reduce global barriers to effective treatment; contribute to the development of evidence-based, ethical treatment policies; contribute to improvement of the quality of pharmacological treatment; and facilitate implementation of effective treatment policies and programs.
Pagination
- Previous page
- Page 84
- Next page